Farallon Capital Boosts UnitedHealth Group Holdings

Hedge fund increases stake in healthcare conglomerate by 16.6% in Q3 2025

Mar. 16, 2026 at 1:20pm

Got story updates? Submit your updates here. ›

Farallon Capital Management LLC, a major investment firm, increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.6% during the third quarter of 2025, according to a recent SEC filing. Farallon now owns 1,886,500 shares of the healthcare conglomerate's stock, valued at approximately $651.41 million, making UnitedHealth Group one of the firm's largest investments.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing insurance, pharmacy, and other healthcare services. Farallon's increased stake in the company signals the hedge fund's confidence in UnitedHealth Group's growth prospects and the overall strength of the healthcare sector.

The details

Farallon Capital Management, a San Francisco-based hedge fund, added 269,200 shares of UnitedHealth Group to its portfolio during the third quarter of 2025. This increased the firm's total holdings in the company to 1,886,500 shares, or approximately 0.21% of UnitedHealth Group's outstanding shares. Farallon's investment in UnitedHealth Group is now the 7th largest position in its portfolio, accounting for around 2.7% of the firm's total assets.

  • Farallon Capital Management increased its UnitedHealth Group holdings during the third quarter of 2025.

The players

Farallon Capital Management LLC

A San Francisco-based hedge fund that manages over $30 billion in assets.

UnitedHealth Group Incorporated

A diversified healthcare company that provides insurance, pharmacy, and other healthcare services in the United States.

Got photos? Submit your photos here. ›

The takeaway

Farallon Capital's increased stake in UnitedHealth Group suggests the hedge fund sees strong growth potential in the healthcare sector, particularly for a major player like UnitedHealth Group that provides a diverse range of services. This investment could signal broader confidence in the healthcare industry's outlook.